Latest Period
Q1 2026
Security Snapshot
REVELATION BIOSCIENCES, INC. - Common stock, par value $0.001 per share (REVB) Institutional Ownership
CUSIP: 76135L705
13F Institutional Holders and Ownership History from Q2 2025 to Q1 2026
Institutions Reporting
0
Shares (Excl. Options)
0
Price
$0.52
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common stock, par value $0.001 per share
- Symbol
- REVB on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 0
- Total 13F value
- $0
- Share change
- -1,178,039
- Value change
- -$941,941
- Number of holders
- 0
- Shares outstanding
- 4,144,115
- SEC-reported price per share
- $0.52
- Insider filing price
- $0.52
Latest holder snapshot
4 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- REVB - REVELATION BIOSCIENCES, INC. - Common stock, par value $0.001 per share is tracked under CUSIP 76135L705.
- 0 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 11 to 0 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $983,945 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 0 institutions filings for Q1 2026.
Security key
76135L705
Latest holder period
Q1 2026
13F holders
0
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
REVB full holder history
REVELATION BIOSCIENCES, INC. SEC filings
REVELATION BIOSCIENCES, INC. company facts
REVELATION BIOSCIENCES, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 76135L705:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
REVB
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 9.6% | $502,733 | 605,702 | SABBY MANAGEMENT, LLC | 31 Dec 2025 | |||
| ARMISTICE CAPITAL, LLC | 7.8% | +56% | $168,085 | +$18,153 | 323,241 | +12% | Armistice Capital, LLC | 31 Mar 2026 |
As of 31 Mar 2026, 0 institutional investors reported holding 0 shares of REVELATION BIOSCIENCES, INC. - Common stock, par value $0.001 per share (REVB). This represents 0% of the company’s total 4,144,115 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
4
Latest
Q1 2026
Rows shown
1-4 of 4